Catalent Q2: Softgel growth blighted by Beinheim plant suspension
Suspension of operations at a French softgel facility reduced Catalent’s second quarter revenues by around $21m, but the firm expects full production to restart in March.
Archives for February 10, 2016
CRO market to reach $45.2bn by 2022
The global healthcare CRO market is expected to reach $45.2bn by 2022, according to a report by Grand View Research.
Recipharm to invest €40m in serialization tech ahead of EU and US track and trace rules
Recipharm will invest €40 in serialization equipment to ensure it can comply with evolving track and trace regulations in the US, Europe and other markets.
Evonik expands silanes distribution deal with Safic-Alcan
Safic-Alcan will sell chemicals used in the synthesis of antibiotics and APIs to drug ingredient firms in Italy under a new deal with Evonik.
Low drug approvals, high costs, spur RBM adoption
With the expectation of new regulatory guidelines, and the need for increased productivity, companies will need to become “comfortable with data,” says Quintiles executive.
GSK is latest to assess VBI Vaccines' biologic stability tech after Sanofi
GSK will test a stability enhancement technology developed by VBI Vaccines in a deal announced this week.